Oxygen therapy for fistulizing Crohn's disease
Part of Digestive system clinical trials.
This study tests whether breathing high-pressure oxygen (hyperbaric oxygen therapy) can help heal fistulas in people with Crohn's disease that hasn't improved with standard treatments. It may help reduce drainage and prevent abscesses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have been diagnosed with Crohn's disease.
- You have at least one fistula (an abnormal tunnel) between your rectum and the skin near your anus, with active drainage or a recent abscess.
- Standard treatments (like azathioprine, methotrexate, biologics, or others) have not worked or caused side effects.
- Your current Crohn's treatment has been stable for at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adjusting the dose of infliximab (a biologic medicine given by IV) based on drug levels in your blood works better for treating draining fistulas caused by Crohn's disease. It is for people who have not tried other biologics and whose fistulas have not healed with usual treatments.
This trial tests whether injecting donated stem cells into complex anal fistulas can help heal them in people with Crohn's disease. You may qualify if you have a fistula that hasn't improved with standard treatments.
This trial tests a drug called risankizumab (Skyrizi) for people whose Crohn's disease has led to anal fistulas that haven't improved with other treatments. The goal is to see if risankizumab can help these fistulas heal and stop draining.
This trial tests a new infrared light treatment to see if it can reduce inflammation and symptoms in people with Crohn's disease. It's for those who have active disease despite current treatments or who are not on therapy.
This trial compares two types of stem cell treatments to help heal complex anal fistulas (abnormal tunnels near the anus). You may be eligible if your Crohn’s-related disease is mostly controlled and the fistula has not fully healed with standard treatments.
This Phase 2 trial studies whether a local injection of fat-derived cells (made from your own tissue) can improve difficult Crohn’s disease fistulas around the anus. It’s designed for people whose Crohn’s fistulas have not responded to usual treatments.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.